Pancreatic Cancer Research

Clinical trialPhase 1Completed

Losartan and Hypofractionated Rx After Chemo for Tx of Borderline Resectable or Locally Advanced Pancreatic Cancer

SHAPER: A Phase 1 Study of Losartan and Hypofractionated Radiation Therapy After Induction Chemotherapy for Borderline Resectable or Locally Advanced Pancreatic Cancer

NCT04106856↗ ClinicalTrials.gov, retrieved 4 November 2026

Outcome
Finished, no results posted
Phase
Phase 1
Status
Completed
Study type
Interventional
Start
8 August 2019
Expected end
17 February 2026
Enrollment
22 participants
Sites
1
Primary outcomes
Rate of dose-limiting toxicities (DLTs)
Sponsor
Other
Results posted
No
Last update
6 July 2026

These are registry fields. A trial card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.

Ask this document

Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.

Try

Papers 7